Prognostic value of coronary artery calcium screening in subjects with and without diabetes.
暂无分享,去创建一个
Daniel S Berman | Leslee J Shaw | Paolo Raggi | D. Berman | T. Callister | L. Shaw | P. Raggi | Tracy Q Callister
[1] R. Detrano,et al. Quantification of coronary artery calcium using ultrafast computed tomography. , 1990, Journal of the American College of Cardiology.
[2] K. Yokote,et al. Hyperglycemia-induced alteration of vascular smooth muscle phenotype. , 2002, Journal of diabetes and its complications.
[3] J. Killian,et al. Coronary atherosclerosis in diabetes mellitus: a population-based autopsy study. , 2002, Journal of the American College of Cardiology.
[4] Tomás Pantoja,et al. Análisis crítico de un artículo Las estatinas reducen la morbi-mortalidad en pacientes de alto riesgo cardiovascular: Heart Protection Study Collaborative Group. (HPS). Lancet 2002; 360: 7-22. , 2003 .
[5] Oluf Pedersen,et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. , 2003, The New England journal of medicine.
[6] W. Roberts,et al. Medial calcinosis of Mönckeberg. A review of the problem and a description of a patient with involvement of peripheral, visceral and coronary arteries. , 1977, The American journal of medicine.
[7] Terje R Pedersen,et al. Cholesterol Lowering With Simvastatin Improves Prognosis of Diabetic Patients With Coronary Heart Disease: A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S) , 1997, Diabetes Care.
[8] A. Jaffe,et al. The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis. The MILIS Study Group. , 1989, Journal of the American College of Cardiology.
[9] E. Barrett-Connor,et al. Prevalence of Cardiovascular and Renal Complications in Older Adults With Normal or Impaired Glucose Tolerance or NIDDM: A population-based study , 1993, Diabetes Care.
[10] R A Carleton,et al. Possible influence of the prospective payment system on the assignment of discharge diagnoses for coronary heart disease. , 1993, The New England journal of medicine.
[11] D. Berman,et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography in patients with diabetes mellitus. , 1999, American heart journal.
[12] M. Laakso,et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. , 1998, The New England journal of medicine.
[13] B. Howard,et al. Diabetes and cardiovascular disease , 2000, Annual review of medicine.
[14] J. Manson,et al. The Impact of Diabetes Mellitus on Mortality From All Causes and Coronary Heart Disease in Women , 2001 .
[15] F Vinicor,et al. The continuing epidemics of obesity and diabetes in the United States. , 2001, JAMA.
[16] Y. Arad,et al. Association of Multiple Risk Factors and Insulin Resistance With Increased Prevalence of Asymptomatic Coronary Artery Disease by an Electron-Beam Computed Tomographic Study , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[17] H. King,et al. Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections , 1998, Diabetes Care.
[18] M Suhonen,et al. Medial artery calcification. A neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitus. , 1996, Arteriosclerosis, thrombosis, and vascular biology.
[19] P. Wilson,et al. Diabetes mellitus and coronary heart disease. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[20] AndrewJ. S. Coats. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial , 2002, The Lancet.
[21] G. Sainani,et al. Diabetes Mellitus and Coronary Artery Disease , 2020 .
[22] S. Yusuf. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Commentary , 2002 .
[23] N. Wareham,et al. Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk) , 2001, BMJ : British Medical Journal.
[24] R. K. Bernstein. Increased prevalence of significant coronary artery calcification in patients with diabetes. , 2001, Diabetes care.
[25] S. Achenbach,et al. Variability of repeated coronary artery calcium measurements by electron beam tomography. , 2001, The American journal of cardiology.
[26] D. Bell. Diabetes mellitus and coronary artery disease. , 1996, Journal of cardiovascular risk.
[27] M. Rubens,et al. The effect of type 1 diabetes mellitus on the gender difference in coronary artery calcification. , 2000, Journal of the American College of Cardiology.
[28] Y. Ueki,et al. Inflammation and insulin resistance are independently related to all-cause of death and cardiovascular events in Japanese patients with type 2 diabetes mellitus. , 2003, Atherosclerosis.
[29] M. Koistinen. Prevalence of asymptomatic myocardial ischaemia in diabetic subjects. , 1990, BMJ.
[30] S. Rich,et al. Increased prevalence of significant coronary artery calcification in patients with diabetes. , 2001, Diabetes care.
[31] D. Berman,et al. Prognostic value of cardiac risk factors and coronary artery calcium screening for all-cause mortality. , 2003, Radiology.
[32] D. Berman,et al. The metabolic syndrome, diabetes, and subclinical atherosclerosis assessed by coronary calcium. , 2003, Journal of the American College of Cardiology.
[33] J. M. Poothullil. Diabetes and decline in heart disease mortality. , 1999, JAMA.
[34] E J Topol,et al. Cause of death in clinical research: time for a reassessment? , 1999, Journal of the American College of Cardiology.
[35] T. Callister,et al. Sensitivity of two electron beam tomography protocols for the detection and quantification of coronary artery calcium. , 2000, AJR. American journal of roentgenology.
[36] W C Willett,et al. The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow-up. , 2001, Archives of internal medicine.
[37] D. Berman,et al. Impact of Diabetes on the Risk Stratification Using Stress Single-Photon Emission Computed Tomography Myocardial Perfusion Imaging in Patients With Symptoms Suggestive of Coronary Artery Disease , 2002, Circulation.
[38] Uk-Prospective-Diabetes-Study-Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) , 1998, The Lancet.
[39] J. W. Box,et al. Influence of diabetes mellitus on clinical outcomes across the spectrum of acute coronary syndromes. Findings from the GUSTO-IIb Study , 2000 .
[40] M. Lauer,et al. Use of stress echocardiography to predict mortality in patients with diabetes and known or suspected coronary artery disease. , 2002, Diabetes care.
[41] R. Holman,et al. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .
[42] Teven,et al. MORTALITY FROM CORONARY HEART DISEASE IN SUBJECTS WITH TYPE 2 DIABETES AND IN NONDIABETIC SUBJECTS WITH AND WITHOUT PRIOR MYOCARDIAL INFARCTION , 2000 .
[43] S. Grundy,et al. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. , 1999, Circulation.
[44] L. Quinn,et al. The prevalence of coronary artery calcium among diabetic individuals without known coronary artery disease. , 2003, Journal of the American College of Cardiology.
[45] Joël Ménard,et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial , 1998, The Lancet.
[46] T. Latifi,et al. Diet-induced Diabetes Activates an Osteogenic Gene Regulatory Program in the Aortas of Low Density Lipoprotein Receptor-deficient Mice* , 1998, The Journal of Biological Chemistry.
[47] R. Detrano,et al. Value of coronary artery calcium scanning by computed tomography for predicting coronary heart disease in diabetic subjects. , 2003, Diabetes care.
[48] F. Marcus,et al. Prognosis of patients with diabetes mellitus after acute myocardial infarction. , 1984, The American journal of cardiology.
[49] L. Broemeling,et al. Coronary artery calcium, coronary artery disease, and diabetes. , 2001, Diabetes research and clinical practice.
[50] D. Grönemeyer,et al. Natural History and Topographic Pattern of Progression of Coronary Calcification in Symptomatic Patients: An Electron-Beam CT Study , 2001, Arteriosclerosis, thrombosis, and vascular biology.
[51] M. Budoff,et al. Diabetes and the associated incidence of subclinical atherosclerosis and coronary artery disease: Implications for management. , 2001, American heart journal.
[52] A. Dziedzic-Gocławska,et al. Crystallinity of mineral deposited in arterial walls in the course of arteriosclerosis in diabetics and in patients with normal carbohydrate metabolism. , 1984, Basic and applied histochemistry.
[53] D. Levy,et al. Prediction of coronary heart disease using risk factor categories. , 1998, Circulation.